The 20 Best Scleroma Doctors Near Me in Silver Spring, MD

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as a Distinguished provider by MediFind in the treatment of Scleroma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Scleroma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema. Dr. Shah is board certified in American Board Of Internal Medicine.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as a Distinguished provider by MediFind in the treatment of Scleroma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma. Dr. Hummers is board certified in American Board Of Internal Medicine.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as a Distinguished provider by MediFind in the treatment of Scleroma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine.

Howard Hauptman is a Rheumatologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 44 years. Dr. Hauptman is rated as a Distinguished provider by MediFind in the treatment of Scleroma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is rated as an Advanced provider by MediFind in the treatment of Scleroma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Myositis, Polymyositis, and Scleroderma.

Zsuzsanna Mcmahan is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Mcmahan is rated as a Distinguished provider by MediFind in the treatment of Scleroma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Localized Scleroderma, and Scleroma.

Donald Thomas is a Rheumatologist practicing medicine in Greenbelt, Maryland. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Scleroma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Osteoporosis, and Postmenopausal Osteoporosis.

Sam Serafi is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Serafi is rated as an Advanced provider by MediFind in the treatment of Scleroma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Raynaud Phenomenon, Sjogren Syndrome, and Rheumatoid Arthritis (RA). Dr. Serafi is board certified in American Board Of Internal Medicine - Rheumatology.

Dr. Ronald Sweren is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous lymphoma/mycosis fungoides, phototherapy/ photopheresis and melanoma. Dr. Sweren also serves as director of the Phototherapy/Photopheresis Program in the Department of Dermatology. Dr. Sweren earned his M.D. from the University of Maryland School of Medicine. He completed his residency in dermatology at University of Maryland Medical Center and in pediatrics at Sinai Hospital of Baltimore. Dr. Sweren is rated as an Experienced provider by MediFind in the treatment of Scleroma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Melanoma, and T-Cell Lymphoma. Dr. Sweren is board certified in American Board Of Dermatology and American Board Of Pediatrics.

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Scleroma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Bullous Pemphigoid, and Pemphigus Foliaceus. Dr. Anhalt is board certified in American Board Of Dermatology.

Dr. Sima Rozati is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. She specializes in medical dermatology, cutaneous lymphoma, and supportive oncodermatology. She received her medical degree from the Shahid Beheshti University of Medical Sciences in Tehran. After completing her internal medicine residency at the Cleveland Clinic, she completed a research fellowship and PhD in cutaneous lymphoma at the University Hospital of Zürich in Switzerland. She returned to the U.S. where she completed cutaneous lymphoma fellowship, under the mentorship of Dr. Youn Kim, followed by dermatology residency at Stanford University School of Medicine in California. In a multidisciplinary environment, Dr. Rozati aims to provide excellent care to patients with cutaneous lymphoma and cancer whom are experiencing cutaneous adverse events from targeted therapies, immune- and chemotherapies. Dr. Rozati’s research interest focuses on cutaneous lymphoma, understanding the biology of this heterogeneous group of malignancies by analyzing the mutational and epigenetic landscape. Her translational research efforts is directed to investigate novel targeted and immunotherapeutic for cutaneous T cell lymphoma. She is a member of different professional organizations, including the American Academy of Dermatology and Woman’s dermatologic Society. Dr. Rozati is rated as an Experienced provider by MediFind in the treatment of Scleroma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Rozati is board certified in American Board Of Dermatology.

Jun Kang is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Scleroma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Localized Scleroderma. Dr. Kang is board certified in American Board Of Dermatology.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Experienced provider by MediFind in the treatment of Scleroma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Melanoma, Hidradenitis Suppurativa, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Alhariri is board certified in American Board Of Dermatology.

Andrea Fava is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Fava is rated as an Experienced provider by MediFind in the treatment of Scleroma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc). Dr. Fava is board certified in American Board Of Internal Medicine.

Christopher Ish, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. He also serves as office medical director at the practice. Dr. Ish received his medical degree from the University of Medicine and Dentistry of New Jersey and completed his residency training in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. He is an instructor of medicine at The Johns Hopkins University School of Medicine in Baltimore. Dr. Ish is rated as an Experienced provider by MediFind in the treatment of Scleroma. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sitosterolemia, and Scleroderma. Dr. Ish is board certified in American Board Of Internal Medicine and American Board Of Pediatrics.

Mark Davino, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Odenton. He received his medical degree from the University of Maryland School of Medicine, and also completed his residency in internal medicine & pediatrics at the University of Maryland Medical Center. Dr. Davino is rated as an Experienced provider by MediFind in the treatment of Scleroma. His clinical expertise encompasses Localized Scleroderma, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Glucocorticoid-Remediable Aldosteronism. Dr. Davino is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Emma Dilorio is a Rheumatologist practicing medicine in Rockville, Maryland. Dr. Dilorio is rated as an Advanced provider by MediFind in the treatment of Scleroma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Psoriasis.

Douglas Lienesch is an Internal Medicine specialist and a Rheumatologist practicing medicine in Elkton, Maryland. Dr. Lienesch is rated as an Advanced provider by MediFind in the treatment of Scleroma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Necrotizing Vasculitis, Light Chain Deposition Disease (LCDD), and IgG4-Related Disease.

Alan Matsumoto is a Rheumatologist practicing medicine in Silver Spring, Maryland. Dr. Matsumoto is rated as an Advanced provider by MediFind in the treatment of Scleroma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Juvenile Primary Osteoporosis.